# Genesystem wins $20M TB diagnostic deal with Genetix Biotech Asia

Genesystem secured a $20 million contract with Genetix Biotech Asia to build a diagnostic kit production facility in India and supply TB test equipment and kits. Completion is set for March 28, 2027.

- Type: Contract
- Announced: 2025-01-03
- Where: India, India
- Value: $20.0M
- Status: announced
- Products: TB diagnostic kits, diagnostic equipment, test kits, consumables
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Genesystem](https://endata.com/companies/82104.md)
- [Genetix Biotech Asia](https://endata.com/companies/82105.md) (customer)

## Sources

- [koreabiomed.com](https://www.koreabiomed.com/news/articleView.html?idxno=26209), 2025-01-03: "With this agreement signals we aim to play a central role in India's TB eradication program."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.